Sarcopenic Obesity in Osteoarthritis vs Rheumatoid Arthritis
Individuals with osteoarthritis may exhibit a higher prevalence of sarcopenic obesity, compared with patients with rheumatoid arthritis.
Individuals with osteoarthritis may exhibit a higher prevalence of sarcopenic obesity, compared with patients with rheumatoid arthritis.
Clinicians conducting pneumococcal vaccination in patients with rheumatoid arthritis should take into consideration the type of RA treatment being used and offer early vaccination.
Temporary methotrexate discontinuation after receiving seasonal influenza vaccination improves the immunogenicity of vaccination in patients with rheumatoid arthritis.
Patients with rheumatoid arthritis who receive TNF inhibitor treatment do not appear to be at increased risk for overall cancer.
A simplified and validated ultrasound scoring system for the evaluation of synovitis in the wrists and hands of patients with rheumatoid arthritis has been proposed.
This study appears to be the first of its kind to use transcranial Doppler to assess intracranial arteries in rheumatoid arthritis.
These results highlight the importance of a multidisciplinary team for treating patients with rheumatoid arthritis.
The presence of the certain autoantibodies accurately predicts a person’s risk for progression from clinically suspect arthralgia to rheumatoid arthritis.
Lowering tumor necrosis factor inhibitor dosage by one-third yielded excellent results in terms of safety, clinical effectiveness, and tolerability in patients with rheumatoid arthritis.
The selective Janus kinase-1 inhibitor filgotinib has shown initial efficacy and adequate safety for the treatment of rheumatoid arthritis.